关注
Valentina R. Garbarino
Valentina R. Garbarino
UT Health San Antonio
在 uthscsa.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biological aging processes underlying cognitive decline and neurodegenerative disease
MM Gonzales, VR Garbarino, E Pollet, JP Palavicini, DL Kellogg, E Kraig, ...
The Journal of clinical investigation 132 (10), 2022
1312022
Mechanisms of oxidative stress resistance in the brain: lessons learned from hypoxia tolerant extremophilic vertebrates
VR Garbarino, ME Orr, KA Rodriguez, R Buffenstein
Archives of biochemistry and biophysics 576, 8-16, 2015
1092015
Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial
MM Gonzales, VR Garbarino, EM Zilli, RC Petersen, JL Kirkland, ...
The journal of prevention of Alzheimer's disease, 1-8, 2022
1012022
Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder
VR Garbarino, TL Gilman, LC Daws, GG Gould
Pharmacological research 140, 85-99, 2019
822019
Extended postnatal brain development in the longest-lived rodent: prolonged maintenance of neotenous traits in the naked mole-rat brain
ME Orr, VR Garbarino, A Salinas, R Buffenstein
Frontiers in neuroscience 10, 504, 2016
532016
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
MM Gonzales, VR Garbarino, TF Kautz, JP Palavicini, M Lopez-Cruzan, ...
Nature medicine 29 (10), 2481-2488, 2023
522023
Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
ME Orr, VR Garbarino, A Salinas, R Buffenstein
Neurobiology of aging 36 (3), 1496-1504, 2015
372015
A geroscience motivated approach to treat Alzheimer’s disease: senolytics move to clinical trials
MM Gonzales, S Krishnamurthy, V Garbarino, AS Daeihagh, GJ Gillispie, ...
Mechanisms of ageing and development 200, 111589, 2021
252021
Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD)–Outcomes from the first clinical trial of senolytic therapy for Alzheimer’s disease
MM Gonzales, VR Garbarino, T Kautz, JP Palavicini, M Lopez-Cruzan, ...
Research square, 2023
212023
Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice
VR Garbarino, TA Santos, AR Nelson, WQ Zhang, CM Smolik, MA Javors, ...
Pharmacological research 140, 21-32, 2019
172019
Phthiraptera and Acari collected from 13 species of Waterfowl from Alabama and Georgia
VR Garbarino, JW Campbell, J O'Brien, HC Proctor, B Dik
Southeastern Naturalist 12 (2), 413-426, 2013
122013
Senolytic therapy to modulate the progression of Alzheimer’s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimer’s Dis 9: 22–29
MM Gonzales, VR Garbarino, E Marques Zilli
82021
A head‐to‐head comparison between senolytic therapies, dasatinib plus quercetin and fisetin, indicates sex‐and genotype‐specific differences in translationally relevant …
VR Garbarino, S Tran, JE Glassman, JL Kirkland, N Musi, S Seshadri, ...
Alzheimer's & Dementia 16, e047607, 2020
42020
Covid‐19 may have a detrimental impact on sensorimotor function
M Goss, R Bernal, VN Patel, K Li, VR Garbarino, RR Nair, HM Snyder, ...
Alzheimer's & Dementia 19, e083191, 2023
12023
Evaluation of Exploratory Fluid Biomarker Results from a Phase 1 Senolytic Trial in Mild Alzheimer’s Disease
VR Garbarino, JP Palavicini, J Melendez, N Barthelemy, Y He, TF Kautz, ...
Research Square, 2024
2024
Disparities in Research Participation within a Multi‐Racial SARS‐CoV‐2 Cohort for Evaluation of Ultrahigh Field (7T) MRI and Clinical Precursors of Alzheimer’s Disease and …
FS Vahidy, AA Hosseini, TD Girard, T Ibrahim, HIL Jacobs, GC Roman, ...
Alzheimer's & Dementia 19, e077318, 2023
2023
Exploration of the tumorigenic, metabolic, and cognitive consequences of tau protein removal
JM Erichsen, VR Garbarino, A Rodriguez, JK Lee, JC Shayne, TC Orr, ...
Alzheimer's & Dementia 19, e073069, 2023
2023
Hippocampal subfield volumes in COVID‐19: a preliminary multicenter study using 7T MRI
T Santini, S Alkateeb, JJ Liou, J Li, OF Adeyemi, GA de Erausquin, ...
Alzheimer's & Dementia 19, e082651, 2023
2023
Lower locus coeruleus integrity in older COVID‐19 survivors: initial findings from an international 7T MRI consortium
HIL Jacobs, T Ibrahim, FS Vahidy, TD Girard, AA Hosseini, S Alkateeb, ...
Alzheimer's & Dementia 19, e080224, 2023
2023
Preliminary neurocognitive finding from a multi‐site study investing long‐term neurological impact of COVID‐19 using ultra‐high field 7 Tesla MRI‐based neuroimaging
JD Tannous, FS Vahidy, R Patira, AM Luckey, MM Gonzales, AA Hosseini, ...
Alzheimer's & Dementia 19, e079210, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20